Interpreting Diverse Genomic Data Using Gene Sets
|
|
- Erick Morgan
- 5 years ago
- Views:
Transcription
1 Interpreting Diverse Genomic Data Using Gene Sets giovanni FHCRC February 2012
2 Gene Sets Leary 2008 PNAS Alterations in the combined FGF, EGFR, ERBB2 and PIK3 pathways. Red: Copy number alterations; Blue: Point mutations.
3 Why gene-set analysis? Improvements in interpretability of experimental results. Detection of subtle correlated changes in sets. Detection of set-level biological signals. Integration of diverse data sources.
4 The birthplaces of gene set analysis: I Tavazoie etal Nature Genetics 2000 Hypergeometric p-value.
5 The birthplaces of gene set analysis: II Mirnics et al Neuron 2000 Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex.
6 A Formalism for Two-Stage Gene Set Analysis Binary response vector Y (phenotype, class label, case-control...) one for each of N samples G N matrix X of genetic information on samples G S binary membership matrix M Stage I Testing of differences between groups for each gene. Compute for each gene g a score s g (X,Y ), capturing the relationship between the genomic measurements and a phenotype of interest. Stage II Testing of differences in scores between sets. Take the scores computed in Stage I as data, and look for association between the scores and the columns of M.
7 The Genetic History of a Cancer Jones 2008 PNAS
8 Landscapes Few high frequency mountains, many low frequency hills
9 Lessons learned from cancer genome projects Integration of genome-wide analyses is important to obtain global picture of genetic alterations Cancers display high degree of complexity and heterogeneity Small number of core pathways are altered in high fraction of human cancers Mutated genes and pathways provide targets for therapeutic and diagnostic intervention
10 Outline, References and Acknowledgments MANY TECHNOLOGIES S. Tyekucheva, L. Marchionni, R. Karchin and G. Parmigiani Integrating diverse genomic data using gene sets. Genome Biol., 12: R105, ATOMS S.M. Boca, H. Corrada Bravo, B. Caffo, J.T. Leek and G. Parmigiani. A decision-theory approach to interpretable set analysis for high-dimensional data. JHU Biostat Working Paper 211, PATIENTS S.M. Boca, K.W. Kinzler, V.E. Velculescu, B. Vogelstein and G. Parmigiani. Patient oriented gene-set analysis for cancer mutation data. Genome Biol., 11: R112, 2010.
11 Multiple data types Phenotype (Pa,ents) Genes Gene s Gene s Gene s Gene s Set C Set A Set B Set Z
12 Gene-centric approaches for multiple data types Binary response vector Y (phenotype, class label, case-control...) G N matrix X of genetic information on samples G S binary membership matrix M Stage I Stage II s g (X 1,...,X D,Y ) t s (s,m s ) Integration sg(x 1 d,y )... sg D (X d,y ) t s (s 1...s D,M s ) Meta-analysis sg(x 1 d,y )... sg D (X d,y ) t s (s 1,M s )... t s (s D,M s ) Visualization
13 Integrative more powerful than Meta-analytic A B Expression 1 Expression 2 CNV 1 CNV 2 LR Avg. p value Min. p value True positive rate Expression 1 Expression 2 CNV 1 CNV 2 LR Avg. p value Min. p value Altered fraction False positive rate Independent Sets ROC for classification of spiked-in sets
14 Integrative more robust than Meta-analytic A B Expression 1 Expression 2 CNV 1 CNV 2 LR Avg. p value Min. p value True positive rate Expression 1 Expression 2 CNV 1 CNV 2 LR Avg. p value Min. p value Altered fraction False positive rate Chromosomal Segments ROC for classification of spiked-in sets
15 Integrative discovers novel sets (a) Synthetic sets Canonical pathways Fraction of exclusively discovered sets Expression 1 Expression 2 CN 1 CN 2 Fraction of exclusively discovered sets Expression 1 Expression 2 CN 1 CN Number of top sets Number of top sets (b) Synthetic sets Canonical pathways Fraction of exclusively discovered sets INT Avg. p value Min. p value Fraction of exclusively discovered sets INT Avg. p value Min. p value Number of top sets Number of top sets
16 GBM Color key Value Color key Value Color key 2 2 Value E2 C2 C2 C2 C1 WNT pathway C1 E2 Stress pathway C1 E2 Glycolysis pathway E1 E1 E1 PGK1 ENO1 TPI1 GPI ALDOB PFKL PKLR HK1 MAP2K4 TRADD MAP2K3 TANK MAP2K6 JUN IKBKG TNFRSF1A MAP3K14 CRADD CASP2 NFKB1 TRAF2 RIPK1 ATF1 CHUK LTA MAP4K2 NFKBIA MAPK14 IKBKB TNF MAPK8 APC WIF1 GSK3B FZD1 CSNK1A1 NLK CTNNB1 HDAC1 MAP3K7 CCND1 CSNK2A1 TLE1 CTBP1 CSNK1D PPARD FRAT1 BTRC AXIN1 MAP3K7IP1 MYC CREBBP
17 Enrichment of 3 intersecting pathways for ER+ BC Wnt pathway 28.7 % (261) 29.4% (225) 14.0% (23) 42.0% (175) Cell cycle 38.0% (235) 27.1% (7) 61.2% (6) 29.0% (31) Ubiquitin mediated proteolysis 26.1% (231) 24.5% (187) X% (Y): X% out of Y genes are estimated to have densities from the alternative distribution.
18 Decision Theoretic Angle Divide genes into atoms based on sets. Truth is the list of alternatives. We search for estimators among the unions of atoms. The estimators are based on the loss function: (1 w) # of FD +w # of MD. The posterior expected loss is: (1 w) EFD + w EMD.
19 Atomic False Discovery Rate We define the atomic false discovery rate for atom A as: AFDR(A) = FD(A)/n A. Theorem (Boca et al., 2010) Atom A is included in the Bayes estimator if and only if the atomic FDR is thresholded by w: ÂFDR(A) w. 1 ÂFDR estimates the fraction of alternatives in an atom.
20 Atomic FDR measures enrichment 1 EFDR p value enrichment fraction enrichment fraction
21 Altered Pathways in Glioblastoma Parsons 2008
22 Gene-centric vs Patient Centric Scores log10(q values) obtained by counting altered samples log10(q values) obtained by combining gene scores
Interpreting Diverse Genomic Data Using Gene Sets
Interpreting Diverse Genomic Data Using Gene Sets giovanni parmigiani@dfci.harvard.edu FHCRC February 2012 Gene Sets Leary 2008 PNAS Alterations in the combined FGF, EGFR, ERBB2 and PIK3 pathways. Red:
More informationIntroduction to Gene Sets Analysis
Introduction to Svitlana Tyekucheva Dana-Farber Cancer Institute May 15, 2012 Introduction Various measurements: gene expression, copy number variation, methylation status, mutation profile, etc. Main
More informationPackage CancerMutationAnalysis
Type Package Package CancerMutationAnalysis Title Cancer mutation analysis Version 1.2.1 Author Giovanni Parmigiani, Simina M. Boca March 25, 2013 Maintainer Simina M. Boca Imports
More informationCancerMutationAnalysis package
CancerMutationAnalysis package Giovanni Parmigiani Dana-Farber Cancer Institute and Harvard School of Public Health email: gp@jimmy.harvard.edu, Simina M. Boca Georgetown University Medical Center email:
More information* Kyoto Encyclopedia of Genes and Genomes.
Supplemental Material Complete gene expression data using Affymetrix 3PRIME IVT ID Chip (54,614 genes) and human immature dendritic cells stimulated with rbmasnrs, IL-8 and control (media) has been deposited
More informationSupplementary figures legends
Supplementary Information to Nijmegen Breakage Syndrome fibroblasts and ipscs: cellular models for uncovering diseaseassociated signaling pathways and establishing a screening platform for anti-oxidants
More informationPlasma-Seq conducted with blood from male individuals without cancer.
Supplementary Figures Supplementary Figure 1 Plasma-Seq conducted with blood from male individuals without cancer. Copy number patterns established from plasma samples of male individuals without cancer
More informationComments on Significance of candidate cancer genes as assessed by the CaMP score by Parmigiani et al.
Comments on Significance of candidate cancer genes as assessed by the CaMP score by Parmigiani et al. Holger Höfling Gad Getz Robert Tibshirani June 26, 2007 1 Introduction Identifying genes that are involved
More informationExpanded View Figures
Solip Park & Ben Lehner Epistasis is cancer type specific Molecular Systems Biology Expanded View Figures A B G C D E F H Figure EV1. Epistatic interactions detected in a pan-cancer analysis and saturation
More informationFigure 1: Effects of cisplatin on survival of lung cancer cells.
Figure 1 Figure 1: Effects of cisplatin on survival of lung cancer cells. To determine the IC 50 concentration of cisplatin, cells were treated with various concentrations of cisplatin and cell survival
More informationSupplementary Material
Supplementary Material Summary: The supplementary information includes 1 table (Table S1) and 4 figures (Figure S1 to S4). Supplementary Figure Legends Figure S1 RTL-bearing nude mouse model. (A) Tumor
More informationSUPPLEMENTARY FIGURES: Supplementary Figure 1
SUPPLEMENTARY FIGURES: Supplementary Figure 1 Supplementary Figure 1. Glioblastoma 5hmC quantified by paired BS and oxbs treated DNA hybridized to Infinium DNA methylation arrays. Workflow depicts analytic
More informationIntegrated Analysis of Copy Number and Gene Expression
Integrated Analysis of Copy Number and Gene Expression Nexus Copy Number provides user-friendly interface and functionalities to integrate copy number analysis with gene expression results for the purpose
More informationSupplementary figures
Supplementary figures Supplementary figure 1: Pathway enrichment for each comparison. The first column shows enrichment with differentially expressed genes between the diet groups at t = 0, the second
More informationCase Study - Informatics
bd@jubilantbiosys.com Case Study - Informatics www.jubilantbiosys.com Validating as a Prognostic marker and Therapeutic Target for Multiple Cancers Introduction Human genome projects and high throughput
More informationRisk-prediction modelling in cancer with multiple genomic data sets: a Bayesian variable selection approach
Risk-prediction modelling in cancer with multiple genomic data sets: a Bayesian variable selection approach Manuela Zucknick Division of Biostatistics, German Cancer Research Center Biometry Workshop,
More informationNature Genetics: doi: /ng Supplementary Figure 1. Mutational signatures in BCC compared to melanoma.
Supplementary Figure 1 Mutational signatures in BCC compared to melanoma. (a) The effect of transcription-coupled repair as a function of gene expression in BCC. Tumor type specific gene expression levels
More informationCancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation
Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated
More informationIntroduction to Computational Neuroscience
Introduction to Computational Neuroscience Lecture 5: Data analysis II Lesson Title 1 Introduction 2 Structure and Function of the NS 3 Windows to the Brain 4 Data analysis 5 Data analysis II 6 Single
More informationSupplementary Figure 1. IHC and proliferation analysis of pten-deficient mammary tumors
Wang et al LEGENDS TO SUPPLEMENTARY INFORMATION Supplementary Figure 1. IHC and proliferation analysis of pten-deficient mammary tumors A. Induced expression of estrogen receptor α (ERα) in AME vs PDA
More informationAn improved hybrid of SVM and SCAD for pathway analysis
www.bioinformation.net Hypothesis Volume 7(4) An improved hybrid of SVM and SCAD for pathway analysis Muhammad Faiz Misman*, Mohd Saberi Mohamad, Safaai Deris, Afnizanfaizal Abdullah, Siti Zaiton Mohd
More informationStatistical Analysis of Single Nucleotide Polymorphism Microarrays in Cancer Studies
Statistical Analysis of Single Nucleotide Polymorphism Microarrays in Cancer Studies Stanford Biostatistics Workshop Pierre Neuvial with Henrik Bengtsson and Terry Speed Department of Statistics, UC Berkeley
More informationSupplementary Materials for
www.sciencetranslationalmedicine.org/cgi/content/full/7/303/303ra139/dc1 Supplementary Materials for Magnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular
More informationMultiplexed Cancer Pathway Analysis
NanoString Technologies, Inc. Multiplexed Cancer Pathway Analysis for Gene Expression Lucas Dennis, Patrick Danaher, Rich Boykin, Joseph Beechem NanoString Technologies, Inc., Seattle WA 98109 v1.0 MARCH
More informationp.r623c p.p976l p.d2847fs p.t2671 p.d2847fs p.r2922w p.r2370h p.c1201y p.a868v p.s952* RING_C BP PHD Cbp HAT_KAT11
ARID2 p.r623c KMT2D p.v650fs p.p976l p.r2922w p.l1212r p.d1400h DNA binding RFX DNA binding Zinc finger KMT2C p.a51s p.d372v p.c1103* p.d2847fs p.t2671 p.d2847fs p.r4586h PHD/ RING DHHC/ PHD PHD FYR N
More informationNature Neuroscience: doi: /nn Supplementary Figure 1. Behavioral training.
Supplementary Figure 1 Behavioral training. a, Mazes used for behavioral training. Asterisks indicate reward location. Only some example mazes are shown (for example, right choice and not left choice maze
More informationCancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation
Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated
More informationAspects of Statistical Modelling & Data Analysis in Gene Expression Genomics. Mike West Duke University
Aspects of Statistical Modelling & Data Analysis in Gene Expression Genomics Mike West Duke University Papers, software, many links: www.isds.duke.edu/~mw ABS04 web site: Lecture slides, stats notes, papers,
More informationModule 3: Pathway and Drug Development
Module 3: Pathway and Drug Development Table of Contents 1.1 Getting Started... 6 1.2 Identifying a Dasatinib sensitive cancer signature... 7 1.2.1 Identifying and validating a Dasatinib Signature... 7
More informationARTICLE RESEARCH. Macmillan Publishers Limited. All rights reserved
Extended Data Figure 6 Annotation of drivers based on clinical characteristics and co-occurrence patterns. a, Putative drivers affecting greater than 10 patients were assessed for enrichment in IGHV mutated
More informationEPIGENETIC RE-EXPRESSION OF HIF-2α SUPPRESSES SOFT TISSUE SARCOMA GROWTH
EPIGENETIC RE-EXPRESSION OF HIF-2α SUPPRESSES SOFT TISSUE SARCOMA GROWTH Supplementary Figure 1. Supplementary Figure 1. Characterization of KP and KPH2 autochthonous UPS tumors. a) Genotyping of KPH2
More informationDevelopment of Carcinoma Pathways
The Construction of Genetic Pathway to Colorectal Cancer Moriah Wright, MD Clinical Fellow in Colorectal Surgery Creighton University School of Medicine Management of Colon and Diseases February 23, 2019
More informationExpert-guided Visual Exploration (EVE) for patient stratification. Hamid Bolouri, Lue-Ping Zhao, Eric C. Holland
Expert-guided Visual Exploration (EVE) for patient stratification Hamid Bolouri, Lue-Ping Zhao, Eric C. Holland Oncoscape.sttrcancer.org Paul Lisa Ken Jenny Desert Eric The challenge Given - patient clinical
More informationCharacteriza*on of Soma*c Muta*ons in Cancer Genomes
Characteriza*on of Soma*c Muta*ons in Cancer Genomes Ben Raphael Department of Computer Science Center for Computa*onal Molecular Biology Soma*c Muta*ons and Cancer Clonal Theory (Nowell 1976) Passenger
More informationComparison of Gene Set Analysis with Various Score Transformations to Test the Significance of Sets of Genes
Comparison of Gene Set Analysis with Various Score Transformations to Test the Significance of Sets of Genes Ivan Arreola and Dr. David Han Department of Management of Science and Statistics, University
More informationMolEcular Taxonomy of BReast cancer International Consortium (METABRIC)
PERSPECTIVE 1 LARGE SCALE DATASET EXAMPLES MolEcular Taxonomy of BReast cancer International Consortium (METABRIC) BC Cancer Agency, Vancouver Samuel Aparicio, PhD FRCPath Nan and Lorraine Robertson Chair
More informationS1 Appendix: Figs A G and Table A. b Normal Generalized Fraction 0.075
Aiello & Alter (216) PLoS One vol. 11 no. 1 e164546 S1 Appendix A-1 S1 Appendix: Figs A G and Table A a Tumor Generalized Fraction b Normal Generalized Fraction.25.5.75.25.5.75 1 53 4 59 2 58 8 57 3 48
More informationSupplementary Figure 1. Copy Number Alterations TP53 Mutation Type. C-class TP53 WT. TP53 mut. Nature Genetics: doi: /ng.
Supplementary Figure a Copy Number Alterations in M-class b TP53 Mutation Type Recurrent Copy Number Alterations 8 6 4 2 TP53 WT TP53 mut TP53-mutated samples (%) 7 6 5 4 3 2 Missense Truncating M-class
More informationFrequency(%) KRAS G12 KRAS G13 KRAS A146 KRAS Q61 KRAS K117N PIK3CA H1047 PIK3CA E545 PIK3CA E542K PIK3CA Q546. EGFR exon19 NFS-indel EGFR L858R
Frequency(%) 1 a b ALK FS-indel ALK R1Q HRAS Q61R HRAS G13R IDH R17K IDH R14Q MET exon14 SS-indel KIT D8Y KIT L76P KIT exon11 NFS-indel SMAD4 R361 IDH1 R13 CTNNB1 S37 CTNNB1 S4 AKT1 E17K ERBB D769H ERBB
More informationIS IT GENETIC? How do genes, environment and chance interact to specify a complex trait such as intelligence?
1 IS IT GENETIC? How do genes, environment and chance interact to specify a complex trait such as intelligence? Single-gene (monogenic) traits Phenotypic variation is typically discrete (often comparing
More informationAVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits
AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits Accelerating clinical research Next-generation sequencing (NGS) has the ability to interrogate many different genes and detect
More informationTerapias personalizadas en cancer
Terapias personalizadas en cancer Atanasio Pandiella Cancer Research Center Salamanca, Spain 20 Aniversario Farmacia Univali, Itajaì Genomic variability of tumors Personalised therapies in cancer To find
More informationcn.mops - Mixture of Poissons for CNV detection in NGS data Günter Klambauer Institute of Bioinformatics, Johannes Kepler University Linz
Software Manual Institute of Bioinformatics, Johannes Kepler University Linz cn.mops - Mixture of Poissons for CNV detection in NGS data Günter Klambauer Institute of Bioinformatics, Johannes Kepler University
More informationSUPPLEMENTARY INFORMATION
doi:10.1038/nature10866 a b 1 2 3 4 5 6 7 Match No Match 1 2 3 4 5 6 7 Turcan et al. Supplementary Fig.1 Concepts mapping H3K27 targets in EF CBX8 targets in EF H3K27 targets in ES SUZ12 targets in ES
More informationClinical evaluation of microarray data
Clinical evaluation of microarray data David Amor 19 th June 2011 Single base change Microarrays 3-4Mb What is a microarray? Up to 10 6 bits of Information!! Highly multiplexed FISH hybridisations. Microarray
More informationExpanded View Figures
Molecular Systems iology Tumor CNs reflect metabolic selection Nicholas Graham et al Expanded View Figures Human primary tumors CN CN characterization by unsupervised PC Human Signature Human Signature
More informationBiomarker adaptive designs in clinical trials
Review Article Biomarker adaptive designs in clinical trials James J. Chen 1, Tzu-Pin Lu 1,2, Dung-Tsa Chen 3, Sue-Jane Wang 4 1 Division of Bioinformatics and Biostatistics, National Center for Toxicological
More informationSupplementary Material. Part I: Sample Information. Part II: Pathway Information
Supplementary Material Part I: Sample Information Three NPC cell lines, CNE1, CNE2, and HK1 were treated with CYC202. Gene expression of 380 selected genes were collected at 0, 2, 4, 6, 12 and 24 hours
More informationSusceptibility Prediction in Familial Colon Cancer
Susceptibility Prediction in Familial Colon Cancer Giovanni Parmigiani gp@jhu.edu Cancer Risk Prediction Models: A Workshop on Development, Evaluation, and Application NCI, May 2004 CROSS-PLATFORM COMPARISON
More informationT-Cell Network Example for GeneNet (August 2015) or later
T-Cell Network Example for GeneNet 1.2.13 (August 2015) or later This note reproduces the T-Cell network example from R. Opgen-Rhein and K. Strimmer. 2006a. Using regularized dynamic correlation to infer
More informationAVENIO ctdna Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB
Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB Analysis Kits Next-generation performance in liquid biopsies 2 Accelerating clinical research From liquid biopsy to next-generation
More informationAsingle inherited mutant gene may be enough to
396 Cancer Inheritance STEVEN A. FRANK Asingle inherited mutant gene may be enough to cause a very high cancer risk. Single-mutation cases have provided much insight into the genetic basis of carcinogenesis,
More informationCPM (x 10-3 ) Tregs +Teffs. Tregs alone ICOS CLTA-4
A 2,5 B 4 Number of cells (x 1-6 ) 2, 1,5 1, 5 CPM (x 1-3 ) 3 2 1 5 1 15 2 25 3 Days of culture 1/1 1/2 1/4 1/8 1/16 1/32 Treg/Teff ratio C alone alone alone alone CD25 FoxP3 GITR CD44 ICOS CLTA-4 CD127
More informationUsing Network Flow to Bridge the Gap between Genotype and Phenotype. Teresa Przytycka NIH / NLM / NCBI
Using Network Flow to Bridge the Gap between Genotype and Phenotype Teresa Przytycka NIH / NLM / NCBI Journal Wisla (1902) Picture from a local fare in Lublin, Poland Genotypes Phenotypes Journal Wisla
More informationSISCR Module 7 Part I: Introduction Basic Concepts for Binary Biomarkers (Classifiers) and Continuous Biomarkers
SISCR Module 7 Part I: Introduction Basic Concepts for Binary Biomarkers (Classifiers) and Continuous Biomarkers Kathleen Kerr, Ph.D. Associate Professor Department of Biostatistics University of Washington
More informationLecture 20. Disease Genetics
Lecture 20. Disease Genetics Michael Schatz April 12 2018 JHU 600.749: Applied Comparative Genomics Part 1: Pre-genome Era Sickle Cell Anaemia Sickle-cell anaemia (SCA) is an abnormality in the oxygen-carrying
More informationarxiv: v1 [stat.ap] 25 Jul 2011
The Annals of Applied Statistics 2011, Vol. 5, No. 2B, 1360 1378 DOI: 10.1214/10-AOAS438 c Institute of Mathematical Statistics, 2011 FALSE DISCOVERY RATES IN SOMATIC MUTATION STUDIES OF CANCER 1 arxiv:1107.4843v1
More informationCoINcIDE: A framework for discovery of patient subtypes across multiple datasets
Planey and Gevaert Genome Medicine (2016) 8:27 DOI 10.1186/s13073-016-0281-4 METHOD CoINcIDE: A framework for discovery of patient subtypes across multiple datasets Catherine R. Planey and Olivier Gevaert
More informationAssociating GWAS Information with the Notch Signaling Pathway Using Transcription Profiling
Cancer Informatics Original Research Open Access Full open access to this and thousands of other papers at http://www.la-press.com. Associating GWAS Information with the Notch Signaling Pathway Using Transcription
More informationFluxion Biosciences and Swift Biosciences Somatic variant detection from liquid biopsy samples using targeted NGS
APPLICATION NOTE Fluxion Biosciences and Swift Biosciences OVERVIEW This application note describes a robust method for detecting somatic mutations from liquid biopsy samples by combining circulating tumor
More informationNext-Gen Analytics in Digital Pathology
Next-Gen Analytics in Digital Pathology Cliff Hoyt, CTO Cambridge Research & Instrumentation April 29, 2010 Seeing life in a new light 1 Digital Pathology Today Acquisition, storage, dissemination, remote
More informationIdentification of Potential Therapeutic Targets by Molecular and Genomic Profiling of 628 Cases of Uterine Serous Carcinoma
Identification of Potential Therapeutic Targets by Molecular and Genomic Profiling of 628 Cases of Uterine Serous Carcinoma Nathaniel L Jones 1, Joanne Xiu 2, Sandeep K. Reddy 2, Ana I. Tergas 1, William
More informationBioimaging and Functional Genomics
Bioimaging and Functional Genomics Elisa Ficarra, EPF Lausanne Giovanni De Micheli, EPF Lausanne Sungroh Yoon, Stanford University Luca Benini, University of Bologna Enrico Macii,, Politecnico di Torino
More informationBayesian Prediction Tree Models
Bayesian Prediction Tree Models Statistical Prediction Tree Modelling for Clinico-Genomics Clinical gene expression data - expression signatures, profiling Tree models for predictive sub-typing Combining
More informationAbstract. Background. Objective
Molecular epidemiology of clinical tissues with multi-parameter IHC Poster 237 J Ruan 1, T Hope 1, J Rheinhardt 2, D Wang 2, R Levenson 1, T Nielsen 3, H Gardner 2, C Hoyt 1 1 CRi, Woburn, Massachusetts,
More informationFONS Nové sekvenační technologie vklinickédiagnostice?
FONS 2010 Nové sekvenační technologie vklinickédiagnostice? Sekvenování amplikonů Sequence capture Celogenomové sekvenování FONS 2010 Sekvenování amplikonů Amplicon sequencing - amplicon sequencing enables
More informationBiostatistical modelling in genomics for clinical cancer studies
This work was supported by Entente Cordiale Cancer Research Bursaries Biostatistical modelling in genomics for clinical cancer studies Philippe Broët JE 2492 Faculté de Médecine Paris-Sud In collaboration
More informationOutlier Analysis. Lijun Zhang
Outlier Analysis Lijun Zhang zlj@nju.edu.cn http://cs.nju.edu.cn/zlj Outline Introduction Extreme Value Analysis Probabilistic Models Clustering for Outlier Detection Distance-Based Outlier Detection Density-Based
More informationExtrastriate Visual Areas February 27, 2003 A. Roe
Extrastriate Visual Areas February 27, 2003 A. Roe How many extrastriate areas are there? LOTS!!! Macaque monkey flattened cortex Why? How do we know this? Topography Functional properties Connections
More informationIdentification and clinical detection of genetic alterations of pre-neoplastic lesions Time for the PML ome? David Sidransky MD Johns Hopkins
Identification and clinical detection of genetic alterations of pre-neoplastic lesions Time for the PML ome? David Sidransky MD Johns Hopkins February 3-5, 2016 Lansdowne Resort, Leesburg, VA Molecular
More informationTADA: Analyzing De Novo, Transmission and Case-Control Sequencing Data
TADA: Analyzing De Novo, Transmission and Case-Control Sequencing Data Each person inherits mutations from parents, some of which may predispose the person to certain diseases. Meanwhile, new mutations
More informationTargeted Agent and Profiling Utilization Registry (TAPUR ) Study. February 2018
Targeted Agent and Profiling Utilization Registry (TAPUR ) Study February 2018 Precision Medicine Therapies designed to target the molecular alteration that aids cancer development 30 TARGET gene alterations
More informationLTA Analysis of HapMap Genotype Data
LTA Analysis of HapMap Genotype Data Introduction. This supplement to Global variation in copy number in the human genome, by Redon et al., describes the details of the LTA analysis used to screen HapMap
More informationCellecta Overview. Started Operations in 2007 Headquarters: Mountain View, CA
Cellecta Overview Started Operations in 2007 Headquarters: Mountain View, CA Focus: Development of flexible, scalable, and broadly parallel genetic screening assays to expedite the discovery and characterization
More informationDNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas
Paul et al. Clinical Epigenetics (2017) 9:32 DOI 10.1186/s13148-017-0331-9 RESEARCH Open Access DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas Yashna Paul, Baisakhi
More informationCell-free tumor DNA for cancer monitoring
Learning objectives Cell-free tumor DNA for cancer monitoring Christina Lockwood, PhD, DABCC, DABMGG Department of Laboratory Medicine 1. Define circulating, cell-free tumor DNA (ctdna) 2. Understand the
More informationOriginal article: DETERMINATION OF THE RELATIONSHIP BETWEEN DOXORUBICIN RESISTANCE AND WNT SIGNALING PATHWAY IN HELA AND K562 CELL LINES
Original article: DETERMINATION OF THE RELATIONSHIP BETWEEN DOXORUBICIN RESISTANCE AND WNT SIGNALING PATHWAY IN HELA AND K562 CELL LINES Pelin Mutlu 1*, Serap Yalçin Azarkan 2, Negar Taghavi Pourianazar
More informationGenomic tests to personalize therapy of metastatic breast cancers. Fabrice ANDRE Gustave Roussy Villejuif, France
Genomic tests to personalize therapy of metastatic breast cancers Fabrice ANDRE Gustave Roussy Villejuif, France Future application of genomics: Understand the biology at the individual scale Patients
More informationVisualizing Cancer Heterogeneity with Dynamic Flow
Visualizing Cancer Heterogeneity with Dynamic Flow Teppei Nakano and Kazuki Ikeda Keio University School of Medicine, Tokyo 160-8582, Japan keiohigh2nd@gmail.com Department of Physics, Osaka University,
More informationNature Genetics: doi: /ng Supplementary Figure 1. SEER data for male and female cancer incidence from
Supplementary Figure 1 SEER data for male and female cancer incidence from 1975 2013. (a,b) Incidence rates of oral cavity and pharynx cancer (a) and leukemia (b) are plotted, grouped by males (blue),
More informationAmerican Psychiatric Nurses Association
Francis J. McMahon International Society of Psychiatric Genetics Johns Hopkins University School of Medicine Dept. of Psychiatry Human Genetics Branch, National Institute of Mental Health* * views expressed
More informationWnt signaling. Ramray Bhat.
Wnt signaling Ramray Bhat ramray@mrdg.iisc.ernet.in Starting with animal biology and viral infections The discovery of certain laboratory murine strains that were highly susceptible to mammary gland cancer.
More informationIdentifying Causal Genes and Dysregulated Pathways in Complex Diseases
Identifying Causal Genes and Dysregulated Pathways in Complex Diseases Yoo-Ah Kim, Stefan Wuchty, Teresa M. Przytycka* National Center for Biotechnology Information, National Library of Medicine, National
More informationPatient networks! in cancer:! a platform for data integration
Anna Goldenberg and The Goldenberg Lab Patient networks! in cancer:! a platform for data integration Outline o Data integra-on problem setup o Pa-ent network representa-on why and how o Similarity Network
More informationMBios 401/501: Lecture 12.1 Signaling IV. Slide 1
MBios 401/501: Lecture 12.1 Signaling IV Slide 1 Pathways that require regulated proteolysis 1. Notch and Delta 2. Wnt/ b-catenin 3. Hedgehog 4. NFk-B Our last topic on cell signaling are pathways that
More informationGenomic analysis of childhood High grade glial (HGG) brain tumors
Genomic analysis of childhood High grade glial (HGG) brain tumors Linda D Cooley Children s Mercy, Kansas City The Children s Mercy Hospital, 2017 Genomic analysis of childhood High grade glial (HGG) brain
More informationDr David Guttery Senior PDRA Dept. of Cancer Studies and CRUK Leicester Centre University of Leicester
Dr David Guttery Senior PDRA Dept. of Cancer Studies and CRUK Leicester Centre University of Leicester dsg6@le.ac.uk CFDNA/CTDNA Circulating-free AS A LIQUID DNA BIOPSY (cfdna) Tumour Biopsy Liquid Biopsy
More informationAdditional file 2 List of pathway from PID
Additional file 2 List of pathway from PID Pathway ID Pathway name # components # enriched GO terms a4b1_paxdep_pathway Paxillin-dependent events mediated by a4b1 20 179 a4b1_paxindep_pathway Paxillin-independent
More informationCancer troublemakers: a tale of usual suspects and novel villains
Cancer troublemakers: a tale of usual suspects and novel villains Abel González-Pérez and Núria López-Bigas Biomedical Genomics Group Lab web: http://bg.upf.edu Driver genes/mutations: the troublemakers
More informationSALSA MLPA KIT P078-B1 Breast Tumour Lot 0210, 0109
SALSA MLPA KIT P078-B1 Breast Tumour Lot 0210, 0109 This P078-B1 Breast Tumour probemix contains probes for several genes (including ERBB2, BIRC5, MYC, TOP2A, ESR1, MTDH, CCND1, CCNE1, EGFR and C11orf30)
More informationWnt signaling in regulation of biological functions of the nurse cell harboring Trichinella spp.
Dabrowska et al. Parasites & Vectors (2016) 9:483 DOI 10.1186/s13071-016-1770-4 SHORT REPORT Open Access Wnt signaling in regulation of biological functions of the nurse cell harboring Trichinella spp.
More informationError Detection based on neural signals
Error Detection based on neural signals Nir Even- Chen and Igor Berman, Electrical Engineering, Stanford Introduction Brain computer interface (BCI) is a direct communication pathway between the brain
More informationFalse Discovery Rates and Copy Number Variation. Bradley Efron and Nancy Zhang Stanford University
False Discovery Rates and Copy Number Variation Bradley Efron and Nancy Zhang Stanford University Three Statistical Centuries 19th (Quetelet) Huge data sets, simple questions 20th (Fisher, Neyman, Hotelling,...
More informationFigure S2. Distribution of acgh probes on all ten chromosomes of the RIL M0022
96 APPENDIX B. Supporting Information for chapter 4 "changes in genome content generated via segregation of non-allelic homologs" Figure S1. Potential de novo CNV probes and sizes of apparently de novo
More informationHow To Use SubpathwayGMir
How To Use SubpathwayGMir Li Feng, Chunquan Li and Xia Li May 20, 2015 Contents 1 Overview 1 2 The experimentally verified mirna-target interactions 2 3 Reconstruct KEGG metabolic pathways 2 3.1 Embed
More informationUniversity of Pittsburgh Cancer Institute UPMC CancerCenter. Uma Chandran, MSIS, PhD /21/13
University of Pittsburgh Cancer Institute UPMC CancerCenter Uma Chandran, MSIS, PhD chandran@pitt.edu 412-648-9326 2/21/13 University of Pittsburgh Cancer Institute Founded in 1985 Director Nancy Davidson,
More informationFigure S4. 15 Mets Whole Exome. 5 Primary Tumors Cancer Panel and WES. Next Generation Sequencing
Figure S4 Next Generation Sequencing 15 Mets Whole Exome 5 Primary Tumors Cancer Panel and WES Get coverage of all variant loci for all three Mets Variant Filtering Sequence Alignments Index and align
More informationNature Methods: doi: /nmeth.3115
Supplementary Figure 1 Analysis of DNA methylation in a cancer cohort based on Infinium 450K data. RnBeads was used to rediscover a clinically distinct subgroup of glioblastoma patients characterized by
More information8/1/2017. Imaging and Molecular Biomarkers of Lung Cancer Prognosis. Disclosures. The Era of Precision Oncology
Imaging and Molecular Biomarkers of Lung Cancer Prognosis Ruijiang Li, PhD Assistant Professor of Radiation Oncology 08/01/2017 Stanford University Department of Radiation Oncology School of Medicine Disclosures
More information